Am J Transplant, Volume 21, Suppl 3 Archives - Page 19 of 139 - ATC Abstracts

2021 American Transplant Congress
De Novo Membranous Nephropathy Associated with Antibody-mediated Rejection in Renal Transplant Recipients
M. V. Sousa¹, L. G. Fernandes², L. L. de Freitas³, R. L. Zollner², M. Mazzali¹
¹Internal Medicine - Division of Nephrology, University of Campinas, Campinas, Brazil, ²Internal Medicine, University of Campinas, Campinas, Brazil, ³Pathology, University of Campinas, Campinas, Brazil
*Purpose: Membranous nephropathy (MN) is a rare autoimmune disease, with the potential to develop a persistent nephrotic syndrome and end-stage chronic renal disease in some…
2021 American Transplant Congress
Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Elevated Plasma Oxalate Level Not Due to Primary Hyperoxaluria
D. Khan, N. Zhang, M. Keddis
Mayo Clinic, Phoenix, AZ
*Purpose: Patients with elevated systemic oxalate burden due to enteric etiologies are at increased risk for calcium oxalate deposition causing ESRD. The objective of this…
2021 American Transplant Congress
An Early Look at the OPTN Kidney Paired Donation Pilot Program’s New Priority Points Policy
S. E. Booker¹, R. Leishman¹, D. E. Stewart¹, T. Sandholm², J. Dickerson³, M. Pavlakis⁴, V. Casingal⁵
¹United Network for Organ Sharing, Richmond, VA, ²Carnegie Mellon University, Pittsburgh, PA, ³University of Maryland, College Park, MD, ⁴Beth Israel Deaconess Medical Center, Boston, MA, ⁵Carolinas Medical Center, Charlotte, NC
*Purpose: The OPTN implemented new policy on 10/24/19 changing how Kidney Paired Donation Pilot Program (KPDPP) priority points are awarded. The policy is intended to…
2021 American Transplant Congress
Perioperative Terlipressin Therapy Reduces the Risk of Acute Kidney Injury Post-Living Donor Liver Transplantation – A Systematic Review and Meta-analysis
A. V. Kulkarni, H. V. Tevethia, M. Sharma, P. Kumar, N. P. Rao, N. D. Reddy
Hepatology and Liver Transplantation, Asian Institute of Gastroenterology, Hyderabad, India
*Purpose: Acute kidney injury (AKI) after liver transplantation precludes calcineurin inhibitors' therapy and is associated with poor outcomes. Terlipressin (Tp) has mortality benefit in pre-transplant…
2021 American Transplant Congress
Quantifying the Interaction Between Posaconazole and Tacrolimus in Liver Transplant Recipients: A Practical Approach
B. Lane¹, U. Kaszubski¹, A. Freeman¹, B. Wise¹, L. Hutchinson¹, M. Janusek¹, G. Therapondos², H. Bohorquez³, S. Anders¹
¹Pharmacy, Ochsner Medical Center, New Orleans, LA, ²Hepatology, Ochsner Medical Center, New Orleans, LA, ³Transplant Surgery, Ochsner Medical Center, New Orleans, LA
*Purpose: The interaction between tacrolimus (FK) and posaconazole (POSA) is well documented, however the extent of this interaction and the practical management has yet to…
2021 American Transplant Congress
Effects of TIPS on Transplant Outcomes for HCC
C. L. Hanlon¹, D. Toy¹, Y. Liu¹, S. Zhou¹, K. Zhou², J. Kahn², L. Yuan²
¹Internal Medicine, University of Southern California, Los Angeles, CA, ²Internal Medicine - Department of Gastroenterology and Hepatology, University of Southern California, Los Angeles, CA
*Purpose: The purpose of this study is to examine effects of TIPS placement on response to locoregional therapy (LRT) and clinical outcomes after liver transplantation…
2021 American Transplant Congress
The Landscape of Non-Directed Living Liver Donation in the United States
L. R. Herbst, L. Zeiser, A. Massie, K. Herrick Reynolds, E. King, A. Gurakar, D. L. Segev, J. Garonzik Wang, A. M. Cameron
Johns Hopkins University, Baltimore, MD
*Purpose: Non-directed donation (NDD) for kidney transplantation has increased substantially over the past decade, however the landscape of NDD for liver transplantation has yet not…
2021 American Transplant Congress
Marginal Allografts in Liver Transplantation Have Very Limited Impact on Length of Stay
C. Goff¹, T. Zhang¹, M. McDonald¹, A. Anand¹, N. Galvan², F. Kanwal³, G. Cholankeril², R. Hernaez³, J. A. Goss⁴, A. Rana²
¹Department of Student Affairs, Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Michael E DeBakey Department of General Surgery, Baylor College of Medicine, Houston, TX, ³Division of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, ⁴Liver Center, Division of Abdominal Transplantation, Department of General Surgery, Baylor College of Medicine, Houston, TX
*Purpose: The purpose of this study was to determine the effect on recipient length of hospital stay following transplantation with marginal allografts as specified by…
2021 American Transplant Congress
Patient Feedback of a Patient and Family Decision Support Tool for Liver Organ Offer Decisions
C. Schaffhausen¹, S. Chu², M. Bruin³, S. Chinnakotla³, J. Lake³, A. Israni⁴
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²University of Minnesota (UMN), Minneapolis, MN, ³UMN, Minneapolis, MN, ⁴Hennepin Healthcare, UMN, Minneapolis, MN
*Purpose: For liver transplant candidates on the waiting list, deciding to accept a donor organ with known or potential risk factors can be stressful and…
2021 American Transplant Congress
Paired Surveillance Biopsies Over >4 Years from a Multi-Center Cohort of 78 Long-Term Pediatric Liver Transplant Recipients
E. R. Perito¹, E. Persyn², J. Bucuvalas³, J. E. Squires⁴, M. Martinez⁵, S. Mohammad⁶, A. J. Demetris⁴, S. Feng¹
¹UCSF, San Francisco, CA, ²King's College, London, United Kingdom, ³Mt. Sinai School of Medicine, NY, NY, ⁴U of Pittsburgh, Pittsburgh, PA, ⁵Columbia U, NY, NY, ⁶Northwestern U, Chicago, IL
*Purpose: Progressive liver fibrosis threatens graft and patient longevity for children after liver transplantation (LT). Previous studies are limited to single-center, cross-sectional analyses. To address…